Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The purinergic receptor P2X3 (P2RX3) is a ligand-gated ion channel activated by extracellular ATP. It is primarily expressed in sensory neurons and mediates fast synaptic transmission of pain signals. It is involved in pain responses, hyperalgesia, allodynia, urinary bladder reflexes, and auditory neuron maturation. Selective antagonism of this receptor has therapeutic potential for treating chronic pain conditions and disorders involving abnormal urine storage or cough reflexes.
Ligand-gated ion channel activation/inhibition
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Purinergic Receptor P2X3 (P2RX3).